Ron Goeree
BA (McMaster), MA (McMaster)
Assistant Professor, Department of Clinical Epidemiology & Biostatistics
Director, Program for Assessment of Technology in Health (PATH)
Chair, Labelle Lectureship Committee
Tel: 905-523-7284 x 5266
Fax: 905-522-0568
E-mail: goereer@mcmaster.ca
Program for Assessment of Technology in Health (P.A.T.H)
25 Main Street West, Suite 2000
Hamilton, Ontario, Canada
L8P 1H1
Contact
Christine Henderson
905-523-7284 x5268
Fax: 905-522-0568
E-mail: hendersc@mcmaster.ca
Academic Interests
Ron Goeree teaches in the Health Research Methodology Program and has recently developed a new course in Advanced Decision Analytic Modeling. Additionally, he is developing a stream for the HRM program with a specific focus on health technology assessment (HTA). HTA is a rapidly growing field internationally with many interesting and challenging career opportunities. The goal of this field specialization is to educate and train individuals who, upon graduation, will have acquired sufficient skills to be actively involved in independent and collaborative research in the field of HTA. Graduates will be expected to acquire a strong foundation not only in the basic principles of HTA, but also in advanced decision analysis, health economics, biostatistics, health services research and health policy analysis. Student stipends at both the Master's and PhD levels for training in HTA may be available.
Current HRM Graduate Students
Natasha Burke
Kelly Anderson
Selected Publications
- Goeree R , Blackhouse G, Petrovic R, Salama S. Cost of stroke in Canada : A one-year prospective study. Journal of Medical Economics. (forthcoming, 2005).
- Weintraub WS, Barnett P, Chen S, Hartigan P, Casperson P, O’Rourke R, Boden WE, Lewis C, Veledar E, Becker E, Culler S, Kolm P, Mahoney E, Dunbar SB, Deaton C, O’Brien BJ, Goeree R, Blackhouse G, Nease R, Spertus J, Kaufman S, Teo, K. Economics methods in the clinical outcomes utilizing percutaneous coronary revascularization aggressive guideline-driven drug evaluation (COURAGE) trial. American Heart Journal (forthcoming, 2005).
- Lynd LD, Goeree R, O’Brien BJ. Antiviral agents for influenza: a comparison of cost-effect iveness data. Pharmacoeconomics 2005; 23(11):1083-106 .
- Goeree R, Farahati, F, Burke N, Blackhouse G, O’Reilly D, Pyne J, Tarride, JE. The economic burden of schizophrenia in Canada in 2004. Current Medical Research and Opinion 2005; 21(12):2017-2028.
- Tang AS, Ross H, Simpson CS, Mitchell LB, Dorian P, Goeree R, Hoffmaster B, Arnold M, Talajic M on behalf of the Canadian Heart Rhythm Society and the Canadian Cardiovascular Society. Canadian Cardiovascular Society / Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator (ICD) use in Canada . Canadian Journal of Cardiology 2005; 21(Suppl A):11A-18A.
- Guyatt GH, Nonoyama M, Lacchetti C, Goeree R, McKim D, Heels-Ansdell D, Goldstein R. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med, 2005;172(5):573-580.
- O’Brien BJ, Blackhouse G, Goeree R, Healey JS, Roberts RS, Gent M, Connolly SJ. Cost-effectiveness of physiologic pacing: results of the Canadian health economic assessment of physiologic pacing. Heart Rhythm 2005;2(3):270-275.
- Willan AR, Pinto EM, O’Brien BJ, Kaul P, Goeree R, Lynd L, Armstrong PW. Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: The Canadian ASSENT-3 economic analysis. Health Economics, 2005;14:327-338.
- Briggs A, Buxton M, Drummond M, Goeree R, Sculpher M, Willan A. Unfinished Symphony: A tribute to the life and career of Bernie O’Brien (1959-2004). Medical Decision Making, 2004;24:538-544.
- Goeree R, O’Brien BJ, Blackhouse G. Principles of good modelling practice in healthcare cost-effectiveness studies. Expert Review Pharmacoeconomics Outcomes Research, 2004;4(2):189-198.

